Secondary prevention of recurrent stroke

Stroke. 2005 Feb;36(2):218-21. doi: 10.1161/01.STR.0000153048.87248.3b. Epub 2005 Jan 6.

Author

Graeme J Hankey¹

Affiliation

¹ Stroke Unit, Department of Neurology, Royal Perth Hospital, School of Medicine & Pharmacology, University of Western Australia, Perth, Australia. gjhankey@cyllene.uwa.edu.au

PMID: 15637323
DOI: 10.1161/01.STR.0000153048.87248.3b

No abstract available

Publication types

Review

MeSH terms

Aspirin / therapeutic use
Clinical Trials as Topic
Clopidogrel
Diabetes Complications / prevention & control
Endarterectomy / methods*
Endarterectomy, Carotid / methods*
Fibrinolytic Agents / therapeutic use
Homocysteine / blood
Humans
Platelet Aggregation Inhibitors / therapeutic use
Risk
Risk Factors
Secondary Prevention*
Stents
Stroke / pathology*
Stroke / prevention & control*
Ticlopidine / analogs & derivatives
Ticlopidine / therapeutic use
Vitamin B Complex / metabolism

Substances

Fibrinolytic Agents
Platelet Aggregation Inhibitors
Homocysteine
Vitamin B Complex
Clopidogrel
Ticlopidine
Aspirin